Ketogenic Diets: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor:
Chrysi C. Koliaki
,
Nicholas L. Katsilambros

Ketogenic diets are very low in carbohydrate, modest in protein, and high in fat. Several systematic reviews and meta-analyses of randomized controlled trials (RCTs) have reported beneficial but short-lived effects of intermittent fasting and ketogenic diets on various obesity-related health outcomes. 

  • time-restricted eating
  • ketogenic diets
  • weight loss
  • cardiometabolic risk factors

1. The Rationale of Ketogenic Diets and Different Variants

The ketogenic diet is unique and distinct from other low-carbohydrate diets such as the Paleo or Atkins diet in that subjects are encouraged to forget nearly all carbohydrates, avoid excess protein, and consume high levels of fat (which generally exceed 70% of total calories consumed), resulting in the production of ketones [1].
The classic ketogenic diet is a high-fat, very-low-carbohydrate diet, which restricts carbohydrate intake to 5–10% of total daily energy intake and replaces the remaining with high amounts of dietary fat (70–80%) and moderate amounts of protein (10–20%) [2]. Depending on the exact weight ratio of dietary fat to combined protein and carbohydrate, it can be further classified into 4:1 and 3:1, and should be always medically supervised. Beyond the classic ketogenic diet, there are also other variants of low-carbohydrate diets which allow more protein or carbohydrate [3], as summarized in Table 1. Ketogenic diets are different from the so-called low-carbohydrate diets. The latter refer to a carbohydrate intake below the recommended dietary allowance of 130 g/day [4], which is usually not sufficiently low to induce nutritional ketosis, whereas in ketogenic diets, carbohydrate intake is restricted to less than 50 g/day.
Table 1. The major types of ketogenic diets.
Variant Description (Macronutrient Composition)
Classic ketogenic diet 4:1 Fat 90%, CHO 2–4%, protein 6–8%
Classic ketogenic diet 3:1 Fat 85–90%, CHO 2–5%, protein 8–12%
Modified Atkins diet Fat 60–65%, CHO 5–10%, protein 25–35%
Ketogenic diet
(as tested in scientific studies)		 CHO intake <50 g/day
Fat 70–80%, CHO <10%, protein 10%
Low-carbohydrate diet CHO intake <130 g/day
Fat variable, CHO 10–25%, protein variable
CHO: carbohydrates.
The major mechanism explaining the weight loss effects of ketogenic diets is associated with reduced insulin levels, which redirects lipid metabolism from storage to oxidation, promotes the use of ketone bodies as alternative fuels, and induces a metabolically beneficial state of nutritional ketosis, which mimics metabolic starvation in the human body [5]. Other possible mechanisms implicated in the weight loss effects of ketogenic diets include: (i) appetite suppression mediated by the higher satiety effect of proteins [6][7], the modulation of appetite-regulating hormones [8], and the direct anorexigenic effect of circulating ketone bodies [9]; (ii) reduced respiratory quotient ratio and greater metabolic efficiency in the direction of fat utilization [10]; (iii) increased metabolic costs of gluconeogenesis and protein-induced thermogenesis [11][12]; and (iv) increased energy expenditure as shown in short-term studies using state-of-the-art technology such as doubly labelled water [13][14].

2. The Current State of Evidence on the Effects of Ketogenic Diets

Table 2 summarizes the major meta-analyses of RCTs in the field of ketogenic diets in humans. In a meta-analysis of 13 RCTs assessing the long-term effects of ketogenic diets (intervention duration longer than one year), it was found that ketogenic diets were associated with less than a kilogram (0.9 kg) of additional weight loss as compared to high-carbohydrate low-fat strategies [4]. Although this difference was found to be statistically significant, it is doubtful whether it is also clinically significant and translates into a meaningful clinical effect. In the same meta-analysis, no significant difference was found in glycemic control (HbA1c) between ketogenic and low-fat diets in patients with T2DM, and there was also no difference in weight loss at 2 years [4].
Table 2. A summary of the major meta-analyses of RCTs in the field of ketogenic diets in humans.
Author
(Year)		 Number of RCTs
Included		 Total Number of Participants
Study Population Characteristics		 Dietary Intervention
vs. Comparator		 Duration of Intervention Major Outcomes
Nordmann
et al. (2006) [15]		 5 n = 447
Overweight/obese		 Ketogenic diet vs. LFDs ≥6 months At 6 months with ketogenic diets:
↓ BW
↓ TG, ↑ HDL, ↓ TC, ↑ LDL
At 12 months:
↔ BW
Hession
et al. (2009) [16]		 13 n = 1222
Overweight/obese		 Ketogenic diet vs. LFDs 6–36 months ↓ BW, TG, SBP
↑ HDL
↓ Attrition rates vs. LFDs
Bueno et al.
(2013) [4]		 13 n = 1577
Overweight/obese
Healthy, T2DM, CVD risk factors		 VLCKD (<50 g CHO/day) vs. LFDs 12–24 months ↓ BW (0.9 kg)
↓ DBP
↓ TG, ↑ HDL, ↑ LDL
Meng et al.
(2017) [17]		 9 n = 734
T2DM		 LCDs (<130 g CHO/day) vs. HCDs 3–24 months ↓ BW (1.18 kg)
↓ TG, ↑ HDL
↔ TC, LDL
No weight loss effects in
long-term RCTs (>12 months)
Sainsbury
et al. (2018) [18]		 25 n = 2412
T2DM		 LCDs (≤45% CHO/day) vs. HCDs (>45% CHO/day) 3–24 months At 3 and 6 months:
↓ HbA1c (only in moderately
CHO-restricted diets with CHO 26–45%)
At 12 and 24 months:
↔ HbA1c
Chawla
et al. (2020) [19]		 38 n = 6499
Normal-weight, overweight, obese adults		 LCDs (<40% CHO, >50% ketogenic) vs. LFDs 1–24 months Small ↓ BW (1.3 kg) with LCDs
(6–12 months)
↑ Variability between studies and individuals
Choi et al.
(2020) [20]		 14 n = 734
Normal-weight, overweight and obese ± T2DM		 Ketogenic diet
vs. LFDs		 4 days -
2 years		 For T2DM patients:
↓ HbA1c, HOMA-IR (3–12 months)
↓ BW (1–12 months)
↓ TG, ↑ HDL (4 days–2 years)
For non-diabetic subjects:
↔ HbA1c, HOMA-IR (3–12 months)
↓ BW (1–12 months)
↑ TC, LDL (4 days-2 years)
Goldenberg
et al. (2021) [21]		 23 n = 1357
T2DM		 LCDs (<26% CHO/day) and VLCKDs (<10% CHO/day) vs. HCDs 3–12 months At 6 months with LCDs:
↑ T2DM remission rates
↓ BW, TG, HOMA-IR
At 12 months with LCDs:
-Sparse data on T2DM remission
-Diminished effects on BW, TG,
HOMA-IRVLCKDs less effective than
LCDs for weight loss at 6 months
↓ adherence with VLCKDs vs. LCDs
at 6 and 12 months
BW: body weight; CHO: carbohydrates; CVD: cardiovascular disease; DBP: diastolic blood pressure; HbA1c: glycated hemoglobin A1c; HCDs: high-carbohydrate diets; HDL: high-density lipoprotein cholesterol; HOMA-IR: homeostasis model assessment for insulin resistance; LCDs: low-carbohydrate diets; LDL: low-density lipoprotein cholesterol; LFDs: low-fat diets; RCTs: randomized controlled clinical trials; SBP: systolic blood pressure; T2DM: type 2 diabetes mellitus; TC: total cholesterol; TG: triglycerides; VLCKDs: very-low-carbohydrate ketogenic diets.
Whether ketogenic diets are better than low-fat diets in terms of body composition changes promoting preferential fat mass loss remains questionable. In a metabolic ward study in 17 overweight or obese men, weight loss accelerated but fat mass loss slowed down for 2 weeks after switching from the baseline to the ketogenic diet [13]. A subsequent metabolic ward study by the same research group tested the effects of an animal-based ketogenic diet compared to a plant-based, carbohydrate-rich, low-fat diet in 20 overweight young adults [14]. Participants were randomized to each diet, which they consumed for 2 weeks before crossing over to the other diet. Total energy intake was lower by nearly 700 kcal/day in the low-fat diet group. The reported hunger and dietary satisfaction scores were similar between groups. Both diets induced weight loss. However, most of the weight lost with the ketogenic diet came from LBM, whereas the low-fat diet resulted in significant losses of body fat after both the first and the second week [14]. The study concluded that low-fat, plant-based diets may control appetite and satiety even better than ketogenic diets contrary to what is commonly believed, and furthermore, that the rapid initial weight loss observed with ketogenic diets is predominantly due to loss of LBM comprising water, glycogen and muscle proteins [14]. These data fuel even more the skepticism regarding the superiority of ketogenic diets over the traditional low-fat hypocaloric dietary approaches.
Subgroup analyses have revealed more pronounced effects of ketogenic diets in overweight/obese and diabetic participants. A meta-analysis of 14 RCTs, comparing ketogenic diets with low-fat diets in subjects with and without T2DM, produced in summary the following findings: (i) ketogenic diets followed for 3–12 months are more effective than low-fat diets for improving glycemic control and insulin sensitivity in patients with T2DM, but their glycemic effects are comparable with those of low-fat diets in non-diabetic individuals; (ii) ketogenic diets followed for 1–12 months are more effective than low-fat diets for weight reduction in overweight and obese subjects, whether they have T2DM or not; (iii) ketogenic diets followed for 4 days up to 2 years have a more beneficial effect on lipid profile compared to low-fat diets only in diabetic patients, by reducing triglycerides and increasing HDL; but (iv) the lipidemic effect of ketogenic diets is adverse in non-diabetic subjects, by increasing total and LDL cholesterol [20]. The effects of carbohydrate-restricted diets on glycemic control in patients with T2DM appear to be most significant within the first 3–6 months and typically wane thereafter [18][21][22][23]. These effects are mainly attributable to weight loss [22][23]. Of note, there is too little evidence to support that ketogenic diets improve glucose intolerance independently of the concurrent weight loss. This is not the case with other dietary approaches such as low-fat diets, in which glycemic control is improved despite the consumption of healthy carbohydrate-rich foods, such as legumes, fruits and whole-grain products, even in the absence of weight loss.
In adults with T1DM, both beneficial and adverse outcomes have been reported. In a small study of 11 adults with T1DM, a ketogenic diet improved glycemic control, but triggered more frequent hypoglycemic episodes and promoted dyslipidemia [24]. In pathophysiological terms, sustained ketosis should be strongly discouraged in patients with T1DM, since it has been associated with oxidative stress, inflammation and insulin resistance [25]. In patients with T2DM participating in clinical trials with ketogenic diets, a common finding is that glucose-lowering medications are frequently reduced or even eliminated [26][27][28][29][30][31][32][33]. With regard to long-term glycemic effects, one open-label, non-randomized, controlled study of the ketogenic diet in patients with T2DM showed a reduction in HbA1c by 1.3% at one year and 0.9% at 2 years, but it should be noted that this group received intensive technological and behavioral support (digitally monitored continuous care intervention), which was not provided to the control group, and this is not always feasible in everyday clinical practice [32][34].
Safety issues and adherence: The potential adverse effects of ketogenic diets range from the relatively benign but unpleasant “keto flu”, which is an induction period of fatigue, weakness and gastrointestinal disturbances, to the less common but more dangerous occurrence of cardiac arrhythmias due to selenium deficiency [1]. Other adverse effects may include nephrolithiasis, constipation, muscle cramps, headaches, bone fractures, pancreatitis, and multiple vitamin and mineral deficiencies [1]. In the absence of multivitamin supplementation, individuals on ketogenic diets are at risk of frank nutritional deficiencies [35]. Even when consuming nutrient-dense foods, the classic ketogenic diet 4:1 can lead to multiple micronutrient shortfalls, often lacking in vitamin K, linolenic acid and water-soluble vitamins [36].
The most important risk, related to ketogenic diets, is the exclusion of fiber and unrefined carbohydrates from the diet, considering that fruits, legumes and whole grains have indispensable effects for human health. Extreme carbohydrate restrictions may profoundly affect diet quality, eliminating fiber sources and increasing the consumption of animal products being rich in cholesterol and saturated fat. In this context, evidence suggests that LDL cholesterol and apo-B-containing lipoprotein levels may fail to improve, or even significantly increase, with a ketogenic diet despite weight loss in healthy adults [37]. In a randomized, controlled, parallel-designed study in 30 young lean adults, a severely carbohydrate-restricted diet with less than 20 g carbohydrate per day for 3 weeks was associated with a significant increase in LDL cholesterol levels by 44% compared to the control habitual diet, and there was a greatly variable individual response [37]. Interestingly, carbohydrate-restricted diets can be linked to either increased or decreased mortality, depending on the quality of carbohydrates consumed and whether they rely more on animal proteins and saturated fat or plant-derived proteins and unsaturated fat, respectively [38]. These diets may also increase the risk of chronic diseases, since dietary components typically increased in ketogenic diets (red processed meat, saturated fat) are linked to an elevated risk of chronic kidney disease, cardiovascular disease, cancer, diabetes, and Alzheimer’s disease [39].
Urinary ketone levels are often used as an indicator of dietary adherence [40]. Ketogenic diets may have poor long-term tolerability and sustainability for many individuals [22][23].
Taking all evidence into consideration, it can be concluded that the risks of ketogenic diets may actually outweigh the potential benefits, since ketogenic diets confer only temporary improvements, they have unfavorable effects on diet quality, and there are currently inadequate data confirming their long-term safety and sustainability [39].

This entry is adapted from the peer-reviewed paper 10.3390/endocrines3040052

References

  1. Joshi, S.; Ostfeld, R.J.; McMacken, M. The Ketogenic Diet for Obesity and Diabetes—Enthusiasm Outpaces Evidence. JAMA Intern. Med. 2019, 179, 1163–1164.
  2. Bough, K.J.; Rho, J.M. Anticonvulsant Mechanisms of the Ketogenic Diet. Epilepsia 2007, 48, 43–58.
  3. Roehl, K.; Sewak, S.L. Practice Paper of the Academy of Nutrition and Dietetics: Classic and Modified Ketogenic Diets for Treatment of Epilepsy. J. Acad. Nutr. Diet 2017, 117, 1279–1292.
  4. Bueno, N.B.; de Melo, I.S.V.; de Oliveira, S.L.; da Rocha Ataide, T. Very-Low-Carbohydrate Ketogenic Diet v. Low-Fat Diet for Long-Term Weight Loss: A Meta-Analysis of Randomised Controlled Trials. Br. J. Nutr. 2013, 110, 1178–1187.
  5. Gershuni, V.M.; Yan, S.L.; Medici, V. Nutritional Ketosis for Weight Management and Reversal of Metabolic Syndrome. Curr. Nutr. Rep. 2018, 7, 97–106.
  6. Westerterp-Plantenga, M.S.; Nieuwenhuizen, A.; Tomé, D.; Soenen, S.; Westerterp, K.R. Dietary Protein, Weight Loss, and Weight Maintenance. Annu. Rev. Nutr. 2009, 29, 21–41.
  7. Veldhorst, M.; Smeets, A.; Soenen, S.; Hochstenbach-Waelen, A.; Hursel, R.; Diepvens, K.; Lejeune, M.; Luscombe-Marsh, N.; Westerterp-Plantenga, M. Protein-Induced Satiety: Effects and Mechanisms of Different Proteins. Physiol. Behav. 2008, 94, 300–307.
  8. Sumithran, P.; Prendergast, L.A.; Delbridge, E.; Purcell, K.; Shulkes, A.; Kriketos, A.; Proietto, J. Ketosis and Appetite-Mediating Nutrients and Hormones after Weight Loss. Eur. J. Clin. Nutr. 2013, 67, 759–764.
  9. Johnstone, A.M.; Horgan, G.W.; Murison, S.D.; Bremner, D.M.; Lobley, G.E. Effects of a High-Protein Ketogenic Diet on Hunger, Appetite, and Weight Loss in Obese Men Feeding Ad Libitum. Am. J. Clin. Nutr. 2008, 87, 44–55.
  10. Paoli, A.; Grimaldi, K.; Bianco, A.; Lodi, A.; Cenci, L.; Parmagnani, A. Medium Term Effects of a Ketogenic Diet and a Mediterranean Diet on Resting Energy Expenditure and Respiratory Ratio. BMC Proc. 2012, 6 (Suppl. S3), P37.
  11. Fine, E.J.; Feinman, R.D. Thermodynamics of Weight Loss Diets. Nutr. Metab. 2004, 1, 15.
  12. Feinman, R.D.; Fine, E.J. Nonequilibrium Thermodynamics and Energy Efficiency in Weight Loss Diets. Biol. Med. Model 2007, 4, 27.
  13. Hall, K.D.; Chen, K.Y.; Guo, J.; Lam, Y.Y.; Leibel, R.L.; Mayer, L.E.S.; Reitman, M.L.; Rosenbaum, M.; Smith, S.R.; Walsh, B.T. Energy Expenditure and Body Composition Changes after an Isocaloric Ketogenic Diet in Overweight and Obese Men. Am. J. Clin. Nutr. 2016, 104, 324–333.
  14. Hall, K.D.; Guo, J.; Courville, A.B.; Boring, J.; Brychta, R.; Chen, K.Y.; Darcey, V.; Forde, C.G.; Gharib, A.M.; Gallagher, I. Effect of a Plant-Based, Low-Fat Diet versus an Animal-Based, Ketogenic Diet on Ad Libitum Energy Intake. Nat. Med. 2021, 27, 344–353.
  15. Nordmann, A.J.; Nordmann, A.; Briel, M.; Keller, U.; Yancy, W.S.; Brehm, B.J.; Bucher, H.C. Effects of Low-Carbohydrate vs Low-Fat Diets on Weight Loss and Cardiovascular Risk Factors: A Meta-Analysis of Randomized Controlled Trials. Arch. Intern. Med. 2006, 166, 285–293.
  16. Hession, M.; Rolland, C.; Kulkarni, U.; Wise, A.; Broom, J. Systematic Review of Randomized Controlled Trials of Low-Carbohydrate vs. Low-Fat/Low-Calorie Diets in the Management of Obesity and Its Comorbidities. Obes. Rev. 2009, 10, 36–50.
  17. Meng, Y.; Bai, H.; Wang, S.; Li, Z.; Wang, Q.; Chen, L. Efficacy of Low Carbohydrate Diet for Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Res. Clin. Pract. 2017, 131, 124–131.
  18. Sainsbury, E.; Kizirian, N.V.; Partridge, S.R.; Gill, T.; Colagiuri, S.; Gibson, A.A. Effect of Dietary Carbohydrate Restriction on Glycemic Control in Adults with Diabetes: A Systematic Review and Meta-Analysis. Diabetes Res. Clin. Pr. 2018, 139, 239–252.
  19. Chawla, S.; Silva, F.T.; Medeiros, S.A.; Mekary, R.A.; Radenkovic, D. The Effect of Low-Fat and Low-Carbohydrate Diets on Weight Loss and Lipid Levels: A Systematic Review and Meta-Analysis. Nutrients 2020, 12, 3774.
  20. Choi, Y.J.; Jeon, S.M.; Shin, S. Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Nutrients 2020, 12, 2005.
  21. Goldenberg, J.Z.; Johnston, B.C. Low and Very Low Carbohydrate Diets for Diabetes Remission. BMJ 2021, 373, n262.
  22. Kosinski, C.; Jornayvaz, F.R. Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. Nutrients 2017, 9, 517.
  23. Brouns, F. Overweight and Diabetes Prevention: Is a Low-Carbohydrate-High-Fat Diet Recommendable? Eur. J. Nutr. 2018, 57, 1301–1312.
  24. Leow, Z.Z.X.; Guelfi, K.J.; Davis, E.A.; Jones, T.W.; Fournier, P.A. The Glycaemic Benefits of a Very-Low-Carbohydrate Ketogenic Diet in Adults with Type 1 Diabetes Mellitus May Be Opposed by Increased Hypoglycaemia Risk and Dyslipidaemia. Diabet Med. 2018, 35, 1258–1263.
  25. Kanikarla-Marie, P.; Jain, S.K. Hyperketonemia and Ketosis Increase the Risk of Complications in Type 1 Diabetes. Free Radic. Biol. Med. 2016, 95, 268–277.
  26. Westman, E.C.; Yancy, W.S.; Mavropoulos, J.C.; Marquart, M.; McDuffie, J.R. The Effect of a Low-Carbohydrate, Ketogenic Diet versus a Low-Glycemic Index Diet on Glycemic Control in Type 2 Diabetes Mellitus. Nutr. Metab. 2008, 5, 36.
  27. Yancy, W.S.; Foy, M.; Chalecki, A.M.; Vernon, M.C.; Westman, E.C. A Low-Carbohydrate, Ketogenic Diet to Treat Type 2 Diabetes. Nutr. Metab. 2005, 2, 34.
  28. Dashti, H.M.; Mathew, T.C.; Khadada, M.; Al-Mousawi, M.; Talib, H.; Asfar, S.K.; Behbahani, A.I.; Al-Zaid, N.S. Beneficial Effects of Ketogenic Diet in Obese Diabetic Subjects. Mol. Cell Biochem. 2007, 302, 249–256.
  29. Hussain, T.A.; Mathew, T.C.; Dashti, A.A.; Asfar, S.; Al-Zaid, N.; Dashti, H.M. Effect of Low-Calorie versus Low-Carbohydrate Ketogenic Diet in Type 2 Diabetes. Nutrition 2012, 28, 1016–1021.
  30. Goday, A.; Bellido, D.; Sajoux, I.; Crujeiras, A.B.; Burguera, B.; García-Luna, P.P.; Oleaga, A.; Moreno, B.; Casanueva, F.F. Short-Term Safety, Tolerability and Efficacy of a Very Low-Calorie-Ketogenic Diet Interventional Weight Loss Program versus Hypocaloric Diet in Patients with Type 2 Diabetes Mellitus. Nutr. Diabetes 2016, 6, e230.
  31. Saslow, L.R.; Mason, A.E.; Kim, S.; Goldman, V.; Ploutz-Snyder, R.; Bayandorian, H.; Daubenmier, J.; Hecht, F.M.; Moskowitz, J.T. An Online Intervention Comparing a Very Low-Carbohydrate Ketogenic Diet and Lifestyle Recommendations Versus a Plate Method Diet in Overweight Individuals With Type 2 Diabetes: A Randomized Controlled Trial. J. Med. Internet Res. 2017, 19, e36.
  32. Athinarayanan, S.J.; Adams, R.N.; Hallberg, S.J.; McKenzie, A.L.; Bhanpuri, N.H.; Campbell, W.W.; Volek, J.S.; Phinney, S.D.; McCarter, J.P. Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Nonrandomized Clinical Trial. Front. Endocrinol. 2019, 10, 348.
  33. Vilar-Gomez, E.; Athinarayanan, S.J.; Adams, R.N.; Hallberg, S.J.; Bhanpuri, N.H.; McKenzie, A.L.; Campbell, W.W.; McCarter, J.P.; Phinney, S.D.; Volek, J.S. Post Hoc Analyses of Surrogate Markers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis in Patients with Type 2 Diabetes in a Digitally Supported Continuous Care Intervention: An Open-Label, Non-Randomised Controlled Study. BMJ Open 2019, 9, e023597.
  34. Hallberg, S.J.; McKenzie, A.L.; Williams, P.T.; Bhanpuri, N.H.; Peters, A.L.; Campbell, W.W.; Hazbun, T.L.; Volk, B.M.; McCarter, J.P.; Phinney, S.D. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018, 9, 583–612.
  35. Bilsborough, S.A.; Crowe, T.C. Low-Carbohydrate Diets: What Are the Potential Short-and Long-Term Health Implications? Asia Pac. J. Clin. Nutr. 2003, 12, 396–404.
  36. Zupec-Kania, B.A.; Spellman, E. An Overview of the Ketogenic Diet for Pediatric Epilepsy. Nutr. Clin. Pract. 2008, 23, 589–596.
  37. Retterstøl, K.; Svendsen, M.; Narverud, I.; Holven, K.B. Effect of Low Carbohydrate High Fat Diet on LDL Cholesterol and Gene Expression in Normal-Weight, Young Adults: A Randomized Controlled Study. Atherosclerosis 2018, 279, 52–61.
  38. Shan, Z.; Guo, Y.; Hu, F.B.; Liu, L.; Qi, Q. Association of Low-Carbohydrate and Low-Fat Diets With Mortality Among US Adults. JAMA Intern. Med. 2020, 180, 513–523.
  39. Crosby, L.; Davis, B.; Joshi, S.; Jardine, M.; Paul, J.; Neola, M.; Barnard, N.D. Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks. Front. Nutr. 2021, 8, 702802.
  40. Newman, J.C.; Verdin, E. β-Hydroxybutyrate: A Signaling Metabolite. Annu. Rev. Nutr. 2017, 37, 51–76.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
ScholarVision Creations
Feedback